124 related articles for article (PubMed ID: 8190092)
41. Properties of the VIP-PACAP type II receptor stably expressed in CHO cells.
Ciccarelli E; Vilardaga JP; De Neef P; Di Paolo E; Waelbroeck M; Bollen A; Robberecht P
Regul Pept; 1994 Dec; 54(2-3):397-407. PubMed ID: 7716273
[TBL] [Abstract][Full Text] [Related]
42. Use of probes with fluorescence indicator distributed throughout the pharmacophore to examine the peptide agonist-binding environment of the family B G protein-coupled secretin receptor.
Harikumar KG; Hosohata K; Pinon DI; Miller LJ
J Biol Chem; 2006 Feb; 281(5):2543-50. PubMed ID: 16319066
[TBL] [Abstract][Full Text] [Related]
43. Regulation of high-conductance anion channels by G proteins and 5-HT1A receptors in CHO cells.
Mangel AW; Raymond JR; Fitz JG
Am J Physiol; 1993 Mar; 264(3 Pt 2):F490-5. PubMed ID: 7681262
[TBL] [Abstract][Full Text] [Related]
44. Real-time evaluation of human secretin receptor activity using cytosensor microphysiometry.
Ng SS; Pang RT; Chow BK; Cheng CH
J Cell Biochem; 1999 Mar; 72(4):517-27. PubMed ID: 10022611
[TBL] [Abstract][Full Text] [Related]
45. Effect of dithiothreitol on the beta-adrenergic receptor of S49 wild type and cyc- lymphoma cells: decreased affinity of the ligand-receptor interaction.
Clark RB; Green DA; Rashidbaigi A; Ruoho A
J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(3):203-20. PubMed ID: 6321573
[TBL] [Abstract][Full Text] [Related]
46. Characterization of receptors for gastrointestinal peptides.
Gardner JD; Jensen RT
Scand J Gastroenterol Suppl; 1983; 82():7-18. PubMed ID: 6314487
[TBL] [Abstract][Full Text] [Related]
47. Role of receptor phosphorylation in desensitization and internalization of the secretin receptor.
Holtmann MH; Roettger BF; Pinon DI; Miller LJ
J Biol Chem; 1996 Sep; 271(38):23566-71. PubMed ID: 8798566
[TBL] [Abstract][Full Text] [Related]
48. Role of charged amino acids conserved in the vasoactive intestinal polypeptide/secretin family of receptors on the secretin receptor functionality.
Di Paolo E; Vilardaga JP; Petry H; Moguilevsky N; Bollen A; Robberecht P; Waelbroeck M
Peptides; 1999; 20(10):1187-93. PubMed ID: 10573290
[TBL] [Abstract][Full Text] [Related]
49. Spatial approximation between secretin residue five and the third extracellular loop of its receptor provides new insight into the molecular basis of natural agonist binding.
Dong M; Lam PC; Pinon DI; Sexton PM; Abagyan R; Miller LJ
Mol Pharmacol; 2008 Aug; 74(2):413-22. PubMed ID: 18467541
[TBL] [Abstract][Full Text] [Related]
50. GTP-dependent stimulation and inhibition of adenylate cyclase.
Cooper DM; Londos C
Horiz Biochem Biophys; 1982; 6():309-33. PubMed ID: 6311719
[No Abstract] [Full Text] [Related]
51. Elucidation of the active conformation of the amino terminus of receptor-bound secretin using intramolecular disulfide bond constraints.
Dong M; Pinon DI; Bordner AJ; Miller LJ
Bioorg Med Chem Lett; 2010 Oct; 20(20):6040-4. PubMed ID: 20813522
[TBL] [Abstract][Full Text] [Related]
52. Epinephrine desensitization of adenylate cyclase from cyc- and S49 cultured lymphoma cells.
Green DA; Friedman J; Clark RB
J Cyclic Nucleotide Res; 1981; 7(3):161-72. PubMed ID: 7287968
[TBL] [Abstract][Full Text] [Related]
53. Lactam constraints provide insights into the receptor-bound conformation of secretin and stabilize a receptor antagonist.
Dong M; Te JA; Xu X; Wang J; Pinon DI; Storjohann L; Bordner AJ; Miller LJ
Biochemistry; 2011 Sep; 50(38):8181-92. PubMed ID: 21851058
[TBL] [Abstract][Full Text] [Related]
54. Different actions of secretin and Gly-extended secretin predict secretin receptor subtypes.
Solomon TE; Varga G; Zeng N; Wu SV; Walsh JH; Reeve JR
Am J Physiol Gastrointest Liver Physiol; 2001 Jan; 280(1):G88-94. PubMed ID: 11123201
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of cholera toxin activation of the adenylate cyclase system in intact HeLa cells.
Lin MC; Taniuchi M
J Cyclic Nucleotide Res; 1980; 6(5):359-67. PubMed ID: 7217459
[TBL] [Abstract][Full Text] [Related]
56. An Mr = 52,000 peptide can mediate effects on cholera toxin on adenylate cyclase in intact cells.
Kaslow HR; Cox D; Groppi VE; Bourne HR
Mol Pharmacol; 1981 May; 19(3):406-10. PubMed ID: 6790933
[No Abstract] [Full Text] [Related]
57. Demonstration of a direct interaction between residue 22 in the carboxyl-terminal half of secretin and the amino-terminal tail of the secretin receptor using photoaffinity labeling.
Dong M; Wang Y; Pinon DI; Hadac EM; Miller LJ
J Biol Chem; 1999 Jan; 274(2):903-9. PubMed ID: 9873030
[TBL] [Abstract][Full Text] [Related]
58. Fluorescence resonance energy transfer analysis of secretin docking to its receptor: mapping distances between residues distributed throughout the ligand pharmacophore and distinct receptor residues.
Harikumar KG; Lam PC; Dong M; Sexton PM; Abagyan R; Miller LJ
J Biol Chem; 2007 Nov; 282(45):32834-43. PubMed ID: 17827151
[TBL] [Abstract][Full Text] [Related]
59. Pharmacology and molecular identification of secretin receptors in rat gastric glands.
Bawab W; Gespach C; Marie JC; Chastre E; Rosselin G
Life Sci; 1988; 42(7):791-8. PubMed ID: 3339956
[TBL] [Abstract][Full Text] [Related]
60. Aequorin functional assay for characterization of G-protein-coupled receptors: implementation with cryopreserved transiently transfected cells.
Jones B; Holskin B; Meyer S; Ung T; Dupriez V; Flores SY; Burgeon E; Ator M; Duzic E
Anal Biochem; 2010 May; 400(2):184-9. PubMed ID: 20109436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
